Guardant Health
GH
#3340
Rank
A$5.36 B
Marketcap
$43.46
Share price
0.07%
Change (1 day)
28.10%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of November 2024 (TTM): 5.49

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is < -1000. At the end of 2024 the company had a P/S ratio of 5.49.

P/S ratio history for Guardant Health from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.49-5.72%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
12.2 122.05%๐Ÿ‡บ๐Ÿ‡ธ USA
3.86-29.78%๐Ÿ‡บ๐Ÿ‡ธ USA